Jason D. Wright, MD

Expertise in: 
Gynecologic Cancers, Cancer Care
Board Certifications: 
Gynecologic Oncology, Obstetrics and Gynecology
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Gynecologic Cancers, Cancer Care, Ovarian Cancer Genetic Susceptibility, Ovarian Cancer, Minimally Invasive Gynecologic Surgery, Laparoscopic Gynecologic Surgery, Gynecologic Cancer, Cervical Cancer, Uterine Cancer

Academic Appointments

  • Sol Goldman Associate Professor of Gynecologic Oncology (in Obstetrics and Gynecology)

Administrative Titles

  • Chief, Division of Gynecologic Oncology

Jason Wright, MD – Chief of Gynecologic Oncology at ColumbiaDoctors

Dr. Wright completed residency and a fellowship in Gynecologic Oncology at Washington University in St. Louis. He is board certified in Obstetrics and Gynecology and Gynecologic Oncology. Dr. Wright sees women with all gynecologic cancers and has extensive training in minimally invasive surgery, extended pelvic resections, and pelvic reconstructive surgery. Dr. Wright also cares for a large number of women with hereditary cancer syndromes. In addition, Dr. Wright sees women with who require complex gynecologic procedures as well as women with placenta accreta.

Dr. Wright is a nationally recognized expert in the treatment of gynecologic cancers and gynecologic surgery. He has authored over 300 articles, chapters, and textbooks. A major focus of Dr. Wright's work is the delivery of quality care to women with cancer and the improvement of outcomes of women with cancer and those who undergo surgery. Dr. Wright's primary clinical research focuses on the evaluation of novel therapeutics, targeted therapies and biologic treatments for women with gynecologic cancers. Dr. Wright is the principal investigator on a number of clinical trials. Dr. Wright is a member of the Alpha Omega Alpha (AOA) Honor Society, a full member of the Society of Gynecologic Oncology, the American Society of Clinical Oncology and a Fellow of the American College of Obstetricians and Gynecologists. Dr. Wright has won numerous teaching and research awards and lectures throughout the United States and internationally.

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Schedule an Appointment

Phone Appointments

New and Existing Patients:
212-305-3410

Location(s)

CUMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
Primary

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • University of Missouri, Kansas City
  • Internship: Barnes Jewish Hospital-Washington University School of Medicine
  • Residency: Barnes Jewish Hospital-Washington University School of Medicine
  • Fellowship: Barnes Jewish Hospital-Washington University School of Medicine

Board Certifications

  • Gynecologic Oncology
  • Obstetrics and Gynecology
America's Top Doctor
NY Top Doctor

Research

Grants

A SINGLE ARE, OPEN LABEL, PHASE IIB STUDY TO ASSESS THE EFFICACY AND SAFETY OF THE COMBINATION CEDIRANIB AND OLAPARIB TABLETS IN WOMEN WITH RECURRENT PLATINUM RESISTANT EPITHELIAL OVARIAN CANCER, INCLUDING FALLOPIAN (P&S Industry Clinical Trial)

Mar 7 2018 - Mar 7 2023

A PHASE III, MULTICENTER, RANDOMIZED, STUDY OF ATEZOLIZUMAB VERSUS PLACEBO ADMINISTERED IN COMBINATION WITH PACLITAXEL, CARBOPLATIN, AND BEVACIZUMAB TO PATIENTS WITH NEWLY-DIAGNOSED STAGE III OR STAGE IVOVARIAN, FALLOPIAN TUBE, (P&S Industry Clinical Trial)

Sep 7 2017 - Sep 7 2022

A BLINDED PROSPECTIVE STUDY OF THE PERFORMANCE OF HE4 TO PREDICT RECURRENCE IN PATIENTS WITH ADVANCED OVARIAN CANCER, PERITONEAL CARCINOMA AND TUBAL CARCINOMA (P&S Industry Clinical Trial)

Oct 28 2014 - Oct 28 2019

A MULTICENTER PROSPECTIVE STUDY OF CA 125 AND HE4 SERUM BIOMARKERS FOR MONITORING THE RESPONSE TO FIRST-LINE THERAPY IN WOMEN WITH PRIMARY EPITHELIAL OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCERS (P&S Industry Clinical Trial)

Oct 28 2014 - Oct 28 2019

COMORBIDITY, TOXICITY AND BREAST CANCER SURVIVAL AMONG WOMEN ON AND OFF CLINICAL TRIALS (Private)

Aug 2 2016 - Aug 1 2019

USING SWOG-MEDICARE DATABASE TO EVALUATE LONG-TERM TOXICITIES OF CANCER SURVIVORS (Federal Gov)

Feb 15 2013 - Jan 31 2018

BREAST CANCER ACCESS TO CARE AND DISPARITIES RESEARCH PROGRAM (Private)

Jan 1 2017 - Dec 31 2017

THE INFLUENCE OF HOSPITAL VARIABILITY ON THE MANAGEMENT OF CANCER-ASSOCIATED COMPLICATIONS (Federal Gov)

Jan 1 2013 - Dec 31 2017

H3E US-X073 (P&S Industry Clinical Trial)

Nov 28 2011 - Nov 28 2016

MORAB-003-004 (P&S Industry Clinical Trial)

Nov 23 2011 - Nov 23 2016

A PHASE 3 PLACEBEO-CONTROLLED STUDY OF CARBOPLATIN/PACLITAXEL WITH OF WITHOUT CONCURRENT AND CONTINUATION MAINTENANCE (Private)

Oct 8 2015 - Oct 7 2016

HIPPOCOMPAL AND COGNITIVE FUNCTION, EXERCISE, AND OVARIAN CANCER: A PILOT STUDY (Federal Gov)

Aug 1 2014 - Jul 31 2016

INFLUENCE OF GEOGRAPHIC VARIATION ON ACCESS TO MINIMALLY INVASIVE GYNECOLOGIC CANCER SURGERY (Private)

Jul 1 2015 - Jun 30 2016

MCH RESEARCH (Federal Gov)

Apr 1 2015 - Mar 31 2016

PHASE II EVALUATION OF CARBOPLATIN,PACLITAXEL AND BEVACIZUMANEOADJUVANT THERAPY FOR EPITHELIAL OVARIAN (P&S Industry Clinical Trial)

May 20 2010 - May 20 2015

ONCOFISH CERVICAL TEST FOR DETECTION OF 3Q26 REGION GAIN (P&S Industry Clinical Trial)

Jun 8 2009 - Dec 31 2014

THERAPEUTIC TARGETING OF NOTCH IN OVARIAN CANCER (Federal Gov)

Jul 1 2009 - Jul 31 2013

ACCEPTANCE OF HUMAN PAPILLOMAVIRUS VACCINATION IN POSTPARTUMWOMEN (P&S Industry Clinical Trial)

May 30 2009 - May 30 2012